Vanessa Kiyomi Ota

Vanessa Kiyomi Ota

Auto-generated profile, based on publicly available information

Vanessa Kiyomi Ota

Post-Graduation Program in Structural and Functional Biology, Universidade Federal de São Paulo, São Paulo, Brazil

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2013 in Schizophrenia Research
Verified
Journal Article
Closed access
AZAndré Zugman
André Zugman
AGAry Gadelha
Ary Gadelha
IAIdaiane Assunção
Idaiane Assunção
JSJoão Sato
João Sato
VOVanessa K. Ota
Vanessa K. Ota
AJAndrea P. Jackowski
Andrea P. Jackowski

1 December 2012 in Schizophrenia Research
Verified
Journal Article
Closed access
VOVanessa Kiyomi Ota
Vanessa Kiyomi Ota
LSLetícia Nery Spíndola
Letícia Nery Spíndola
AGAry Gadelha
Ary Gadelha
AFAirton Ferreira dos Santos Filho
Airton Ferreira dos Santos Filho
MSMarcos Leite Santoro
Marcos Leite Santoro
SBSintia Iole Belangero
Sintia Iole Belangero

1 November 2014 in Schizophrenia Research
Verified
Journal Article
Closed access
VOVanessa Kiyomi Ota
Vanessa Kiyomi Ota
CNCristiano Noto
Cristiano Noto
AGAry Gadelha
Ary Gadelha
MSMarcos Leite Santoro
Marcos Leite Santoro
LSLeticia Maria Spindola
Leticia Maria Spindola
SBSintia Iole Belangero
Sintia Iole Belangero

21 October 2019 in Clinical Epigenetics
Verified
Journal Article
Open access
PDF file
LSLeticia M. Spindola
Leticia M. Spindola
MSMarcos L. Santoro
Marcos L. Santoro
PPPedro Pan
Pedro Pan
VOVanessa K. Ota
Vanessa K. Ota
GXGabriela Xavier
Gabriela Xavier
SBSintia I. Belangero
Sintia I. Belangero
Background: Psychiatric symptomatology during late childhood and early adolescence tends to persist later in life. In the present longitudinal study, we aimed to identify changes in genome-wide DNA methylation patterns that were associated with the emergence of psychopathology in youths from the Brazilian High-Risk Cohort (HRC) for psychiatric disorders. Moreover, for the differentially methylated genes, we verified whether differences in DNA methylation corresponded to differences in mRNA transcript levels by analyzing the gene expression levels in the blood and by correlating the variation of DNA methylation values with the variation of mRNA levels of the same individuals. Finally, we examined whether the variations in DNA methylation and mRNA levels were correlated with psychopathology measurements over time.Methods: We selected 24 youths from the HRC who presented with an increase in dimensional psychopathology at a 3-year follow-up as measured by the Child Behavior Checklist (CBCL). The DNA methylation and gene expression data were compared in peripheral blood samples (n = 48) obtained from the 24 youths before and after developing psychopathology. We implemented a methodological framework to reduce the effect of chronological age on DNA methylation using an independent population of 140 youths and the effect of puberty using data from the literature.Results: We identified 663 differentially methylated positions (DMPs) and 90 differentially methylated regions (DMRs) associated with the emergence of psychopathology. We observed that 15 DMPs were mapped to genes that were differentially expressed in the blood; among these, we found a correlation between the DNA methylation and mRNA levels ofRB1CC1and a correlation between the CBCL and mRNA levels ofKMT2E.Of the DMRs, three genes were differentially expressed:ASCL2, which is involved in neurogenesis;HLA-E, which is mapped to the MHC loci; andRPS6KB1, the gene expression of which was correlated with an increase in the CBCL between the time points.Conclusions: We observed that changes in DNA methylation and, consequently, in gene expression in the peripheral blood occurred concurrently with the emergence of dimensional psychopathology in youths. Therefore, epigenomic modulations might be involved in the regulation of an individual’s development of psychopathology.

28 March 2019 in Schizophrenia
Verified
Journal Article
Open access
PDF file
VOVanessa Kiyomi Ota
Vanessa Kiyomi Ota
PMPatricia Natalia Moretti
Patricia Natalia Moretti
MSMarcos Leite Santoro
Marcos Leite Santoro
FTFernanda Talarico
Fernanda Talarico
LSLeticia Maria Spindola
Leticia Maria Spindola
SBSintia I. Belangero
Sintia I. Belangero
The study of patients with schizophrenia (SZ) at different clinical stages may help clarify what effects could be due to the disease itself, to the pharmacological treatment, or to the disease progression. We compared expression levels of targeted genes in blood from individuals in different stages of SZ: clinical high risk for psychosis (CHR), first episode of psychosis (FEP), and chronic SZ (CSZ). Then, we further verified whether single-nucleotide polymorphisms (SNPs) could be related to gene expression differences. We investigated 12 genes in 394 individuals (27 individuals with CHR, 70 antipsychotic-naive individuals with FEP, 157 CSZ patients, and 140 healthy controls (HCs)). For a subsample, genotype data were also available, and we extracted SNPs that were previously associated with the expression of selected genes in whole blood or brain tissue. We generated a mediation model in which a putative cause (SNP) is related to a presumed effect (disorder) via an intermediate variable (gene expression). MBP and NDEL1 were upregulated in FEP compared to all other groups; DGCR8 was downregulated in FEP compared to HC and CHR; DGCR2 was downregulated in CSZ compared to FEP and HCs; DISC1 was upregulated in schizophrenia compared to controls or FEP, possibly induced by the rs3738398 and rs10864693 genotypes, which were associated with DISC1 expression; and UFD1 was upregulated in CSZ and CHR compared to FEP and HC. Our results indicated changes in gene expression profiles throughout the different clinical stages of SZ, reinforcing the need for staging approaches to better capture SZ heterogeneity.

1 April 2013 in Schizophrenia Research
Verified
Journal Article
Closed access
VOVanessa K. Ota
Vanessa K. Ota
AGAry Gadelha
Ary Gadelha
IAIdaiane B. Assunção
Idaiane B. Assunção
MSMarcos L. Santoro
Marcos L. Santoro
DCDenise M. Christofolini
Denise M. Christofolini
AJAndrea P. Jackowski
Andrea P. Jackowski